Bowen's disease: Difference between revisions
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) |
||
Line 484: | Line 484: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''[[Superficial]] [[basal cell carcinoma]]''' | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''[[Superficial]] [[basal cell carcinoma]]''' | ||
|Common causes include: | |Common causes include: | ||
* Radiation exposure[[Sunlight|(sunlight]] ([[UV light]]), [[Tanning booths|tanning beds]], and [[x-rays]]) | |||
* [[TP53 (gene)|TP53 gene]] [[mutations]] | |||
* Inappropriate activation of the [[hedgehog signaling pathway]] ([[Loss function|loss-of-function]] [[mutations]] in [[Tumor-suppressor gene|tumor-suppressor]][[protein]] patched homologue 1 ([[PTCH1]]) | |||
* [[Gain-of-function mutation|Gain-of-function mutations]] in [[sonic hedgehog]] (SHH), [[smoothened]] (SMO) | |||
* Xeroderma pigmentosum | |||
* Epidermodysplastic verruciformis | |||
* Nevoid basal cell carcinoma syndrome | |||
* Bazex Syndrome | |||
* Rombo syndrome | |||
* | * |
Revision as of 23:55, 31 July 2019
Template:DiseaseDisorder infobox
WikiDoc Resources for Bowen's disease |
Articles |
---|
Most recent articles on Bowen's disease Most cited articles on Bowen's disease |
Media |
Powerpoint slides on Bowen's disease |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Bowen's disease at Clinical Trials.gov Trial results on Bowen's disease Clinical Trials on Bowen's disease at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Bowen's disease NICE Guidance on Bowen's disease
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Bowen's disease Discussion groups on Bowen's disease Patient Handouts on Bowen's disease Directions to Hospitals Treating Bowen's disease Risk calculators and risk factors for Bowen's disease
|
Healthcare Provider Resources |
Causes & Risk Factors for Bowen's disease |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2] Jesus Rosario Hernandez, M.D. [3]
Synonyms and keywords: Bowen's carcinoma; squamous cell carcinoma in situ of skin; intraepidermal carcinoma skin
Overview
In medicine (dermatology), Bowen's disease (BD) is a sunlight-induced skin disease, classified either as an early noninvasive stage or intraepidermal form of squamous cell carcinoma which if left undiagnosed, untreated, or neglected has <10% chance of malignant transformation into invasive squamous cell carcinoma of the skin. It usually appears as a erythematous, scaly or crusty patch or plaque anywhere on the body but most commonly involves lower legs, with other possible sites of involvement to be head, neck, genitals, and skin folds. It is easily curable by various treatment options such as cryotherapy, curettage, cautery, photodynamic therapy, topical chemotherapy, radiotherapy, or excision of the lesion.
Historical Perspective
Pathophysiology
Microscopic Pathology
- Cells in Bowen's disease are extremely unusual or atypical under the microscope[1]
- In many cases, cells look worse under the microscope than the cells of many outright and invading squamous cell carcinomas
- Degree of atypia (strangeness, unusualness) seen under the microscope best tells how cells may behave (should they invade another portion of the body)[2][3]
- Borst-Jadassohn phenomenon[4][5]
Causes
Bowen's disease is a non-infectious, non-familial disease with common causes as mentioned below:
- Solar damage due to long-term sun exposure or use of sunbeds, especially in people with fair skin
- Aging
- Carcinogens such as arsenic:
- Weak immune system due to:
- Viral infection such as:
- Different types HPV/human papillomavirus:[6][7][8][9][10][11][12]
- HPV 16, 18, 34, and 48 are associated with Bowen's disease of perianal & genital region especially bowenoid papulosis and VIN are caused by HPV 16
- HPV 2, 16, 34, and 35 are associated with Bowen's disease in other areas of body (excluding genitals)
- 47% of acral and 24% of nonacral extragenital Bowen's disease lesion contains HPV genome
- Merkel cell polyomavirus
- Different types HPV/human papillomavirus:[6][7][8][9][10][11][12]
- Previous irradiation such as:
- Ultraviolet irradiation
- Radiotherapy treatment
- Photochemotherapy
- Chronic skin injury
- Dermatoses
- Sjögren's syndrome
Epidemiology and Demographics
Age
- Bowen's disease can affect adults of any age, most commonly involves older patients in their 60s or 70s
- It is rare before the age of 30 years
Gender
- Bowen's disease occurs more predominantly in men than in women (70-85% of cases)
Race
- Caucasians are the ones most commonly affected by Bowen's disease
Natural History, Complications and Prognosis
- Bowen's disease grows very slowly over the period of months or even years[13]
- It is easily treatable if diagnosed in time
- If left undiagnosed, untreated or neglected, Bowen's disease can ultimately progressively develop into invasive squamous cell carcinoma of the skin in 1 in 20-30 people (i.e. 3-5% risk)
- SCC is a treatable condition, but if it's deeper or invasive, it means it's very serious
Diagnosis
Common symptoms
- It usually appears as one or more skin patches with following characteristics:[13]
Signs and symptoms of malignant transformation
- Following changes in the skin patch are the signs that bowen's disease has turned into invasive squamous cell carcinoma of the skin:
Common sites of involvement
Skin
- Lesions can occur anywhere on the skin surface or on mucosal surfaces, although the involvement of palms or soles is uncommon
- A persistent progressive non-elevated red scaly or crusted plaque which is due to an intradermal carcinoma and is potentially malignant
- Atypical squamous (resembling fish scales) cells proliferate through the whole thickness of the epidermis
Extremities
- About three-quarters of the patients have lesions on the lower leg (60-85%), usually in previously or presently sun-exposed areas of skin
Head and neck area
- Being prone to the sun exposure, head and neck area is also one of the common sites to be affected by Bowen's disease
Subungal, periungal region
- Bowen's disease also commonly involves subungal or periungal areas (i.e. either under or around fingernails or toenails)
Skinfolds
Genitourinary system
- Bowen's disease can also involve genital and perianal areas
- It appears in following 3 forms in genital area:[17]
Bowen's disease form | Characteristic features |
---|---|
Bowenoid papulosis | |
Erythroplasia of Queyrat |
|
Vulvar intraepithelial neoplasia (VIN) |
Physical Examination
- Bowen's disease typically presents as a gradually enlarging, well demarcated erythematous plaque with an irregular border and surface crusting or scaling[18][19][20]
- Lesion might feel tender representing its malignant transformation
Dermoscopy
Skin biopsy
- Skin biopsy must be done to:
- Confirm the diagnosis Bowen's disease
- Differentiate from other skin lesions
- Rule out invasive squamous cell carcinoma of the skin
Treatment
- Specific treatment for an individual case depends upon various factors, such as:[21]
- Different treatment options for Bowen's disease include the following:
Treatment option | Details |
---|---|
Watch and wait | |
Cryosurgery/Freezing | |
Topical cream |
|
Curettage & electrodesiccation or cryotherapy |
|
Cauterization or diathermy coagulation[22] | |
Photodynamic therapy (PDT)[23][24][25][26][27][28] | |
Radiation therapy[29][30][31][32][33][34] | |
Excision | |
Mohs micrographic surgery |
|
Prevention
Following are the few preventive measures to lower the risk for developing Bowen's disease:
Preventive method | Details |
---|---|
Avoiding sunburns and suntans | |
Wearing protective clothing | Wear the following while being in the outdoor environment: |
Wearing SPF sunscreen | |
Avoiding tanning beds |
|
Being aware of sun-sensitizing medications |
|
Checking skin regularly and reporting any new or unusual skin changes to the doctor |
|
Reducing the exposure to ultraviolet (UV) radiation, especially during the early years of life |
|
Differentiating Bowen's disease from other Diseases
- Bowen's disease must be differentiated from the following:
Disease entity | Etiology | Pathology | Common sites of involvement | Clinical manifestations | Images | |
---|---|---|---|---|---|---|
Bowen's disease | Common causes include:
|
Histopathology shows:
|
Most commonly involves:
|
|
| |
Psoriasis |
|
Histopathology shows:
|
Involves:
|
|
| |
Eczema | Common causes include:
|
|
Involves:
|
|
| |
Superficial basal cell carcinoma | Common causes include:
|
|
|
|
| |
Actinic keratosis |
| |||||
Seborrheic keratosis |
| |||||
Lichen planus |
| |||||
Tinea corporis |
| |||||
Extramammary Paget’s disease |
|
References
- ↑ Neagu TP, Tiglis M, Botezatu D, Enache V, Cobilinschi CO, Vâlcea-Precup MS, GrinTescu IM (2017). "Clinical, histological and therapeutic features of Bowen's disease". Rom J Morphol Embryol. 58 (1): 33–40. PMID 28523295.
- ↑ Nemkaeva RM, Kurmashov NA, Oslopova S (1988). "[Bowen's disease]". Vestn Dermatol Venerol (8): 71–2. PMID 3195216.
- ↑ Scarborough DA, Bisaccia EP, Yoder FW (1982). "Solitary pigmented Bowen's disease". Arch Dermatol. 118 (11): 954–5. PMID 7138058.
- ↑ Yanagihara S, Oiso N, Hirota N, Kato M, Miyake S, Kawada A (2019). "Acantholytic Bowen's disease histopathologically showing the Borst-Jadassohn phenomenon". Eur J Dermatol. doi:10.1684/ejd.2019.3545. PMID 31145080.
- ↑ Baykal C, Buyukbabani N, Babuna G, Polat Ekinci A, Kurul S (2016). "Giant Bowen's disease histologically showing Borst-Jadassohn phenomenon and complicated with squamous cell carcinoma development". J Eur Acad Dermatol Venereol. 30 (10): e88–e89. doi:10.1111/jdv.13335. PMID 26373350.
- ↑ Clavel CE, Huu VP, Durlach AP, Birembaut PL, Bernard PM, Derancourt CG (1999). "Mucosal oncogenic human papillomaviruses and extragenital Bowen disease". Cancer. 86 (2): 282–7. PMID 10421264.
- ↑ Zheng S, Adachi A, Shimizu M, Shibata SI, Yasue S, Sakakibara A; et al. (2005). "Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen's disease". Br J Dermatol. 152 (6): 1243–7. doi:10.1111/j.1365-2133.2005.06643.x. PMID 15948988.
- ↑ Lampert A, Pauwels C, Duboucher C, Morel G, Poveda JD, Périé G (2000). "[Detection of human papillomavirus in cutaneous extragenital Bowen's disease in immunocompetent patients]". Ann Dermatol Venereol. 127 (1): 40–5. PMID 10717561.
- ↑ Collina G, Rossi E, Bettelli S, Cook MG, Cesinaro AM, Trentini GP (1995). "Detection of human papillomavirus in extragenital Bowen's disease using in situ hybridization and polymerase chain reaction". Am J Dermatopathol. 17 (3): 236–41. PMID 8599431.
- ↑ Derancourt C, Mougin C, Chopard Lallier M, Coumes-Marquet S, Drobacheff C, Laurent R (2001). "[Oncogenic human papillomaviruses in extra-genital Bowen disease revealed by in situ hybridization]". Ann Dermatol Venereol. 128 (6–7): 715–8. PMID 11460032.
- ↑ Pham-Huu V, Derancourt C, Clavel C, Durlach A, Birembaut P, Bernard P (1999). "[Oncogenic mucosal human papillomaviruses in Bowen's disease of the hands]". Ann Dermatol Venereol. 126 (11): 808–12. PMID 10612858.
- ↑ Murao K, Yoshioka R, Kubo Y (2014). "Human papillomavirus infection in Bowen disease: negative p53 expression, not p16(INK4a) overexpression, is correlated with human papillomavirus-associated Bowen disease". J. Dermatol. 41 (10): 878–84. doi:10.1111/1346-8138.12613. PMID 25201325.
- ↑ 13.0 13.1 "Bowen's disease - NHS".
- ↑ Wagner RF, Grande DJ (1986). "Solitary pigmented Bowen's disease of the scrotum". J Dermatol Surg Oncol. 12 (10): 1114–5. PMID 3760318.
- ↑ Al-Dawsari NA, Raslan W, Dawamneh MF (2014). "Pigmented Bowen's disease of the penis and scrotum in a patient with AIDS". Dermatol Online J. 20 (4): 22337. PMID 24746300.
- ↑ Narahira A, Yanagi T, Kitamura S, Hata H, Shimizu H (2019). "Dermoscopic features of genital pigmented Bowen's disease: Report of a case and review of the published work". J Dermatol. doi:10.1111/1346-8138.14938. PMID 31141219.
- ↑ "Bowen's Disease: Skin Cancer Linked to HPV Infection".
- ↑ Inoue T, Kobayashi K, Sawada M, Ishizaki S, Ito H, Fujibayashi M; et al. (2010). "Dermoscopic Features of Pigmented Bowen's Disease in a Japanese Female Mimicking Malignant Melanoma". Dermatol Res Pract. 2010. doi:10.1155/2010/543091. PMC 2929512. PMID 20811602.
- ↑ Hayashi Y, Tanaka M, Suzaki R, Mori N, Konohana I (2009). "Dermoscopy of Pigmented Bowen's Disease Mimicking Early Superficial Spreading Melanoma". Case Rep Dermatol. 1 (1): 11–15. doi:10.1159/000227284. PMC 2895203. PMID 20652107.
- ↑ Yang Y, Lin J, Fang S, Han S, Song Z (2017). "What's new in dermoscopy of Bowen's disease: two new dermoscopic signs and its differential diagnosis". Int J Dermatol. 56 (10): 1022–1025. doi:10.1111/ijd.13734. PMID 28832993.
- ↑ "Bowen Disease - NORD (National Organization for Rare Disorders)".
- ↑ Neubert T, Lehmann P (2008). "Bowen's disease - a review of newer treatment options". Ther Clin Risk Manag. 4 (5): 1085–95. PMC 2621408. PMID 19209288.
- ↑ Wong TW, Sheu HM, Lee JY, Fletcher RJ (2001). "Photodynamic therapy for Bowen's disease (squamous cell carcinoma in situ) of the digit". Dermatol Surg. 27 (5): 452–6. PMID 11359493.
- ↑ Britton JE, Goulden V, Stables G, Stringer M, Sheehan-Dare R (2005). "Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy". Br J Dermatol. 153 (4): 780–4. doi:10.1111/j.1365-2133.2005.06830.x. PMID 16181460.
- ↑ Kang HK, Yun JH, Son YM, Roh JY, Lee JR (2014). "Photodynamic Therapy for Bowen's Disease of the Vulva Area". Ann Dermatol. 26 (2): 241–5. doi:10.5021/ad.2014.26.2.241. PMC 4037679. PMID 24882981.
- ↑ Dijkstra AT, Majoie IM, van Dongen JW, van Weelden H, van Vloten WA (2001). "Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma". J Eur Acad Dermatol Venereol. 15 (6): 550–4. PMID 11843215.
- ↑ Harth Y, Hirshowitz B, Kaplan B (1998). "Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia". Dermatol Surg. 24 (7): 723–6. PMID 9693665.
- ↑ de Haas ER, de Vijlder HC, Sterenborg HJ, Neumann HA, Robinson DJ (2008). "Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer". J Eur Acad Dermatol Venereol. 22 (4): 426–30. doi:10.1111/j.1468-3083.2007.02445.x. PMID 18031503.
- ↑ Anna Z, John K, Maria T, George K, Ivelina B, Ioanna K; et al. (2012). "The potential role of radiation therapy in Bowen's disease: a review of the current literature". Rev Recent Clin Trials. 7 (1): 42–6. PMID 21864250.
- ↑ Lukas VanderSpek LA, Pond GR, Wells W, Tsang RW (2005). "Radiation therapy for Bowen's disease of the skin". Int J Radiat Oncol Biol Phys. 63 (2): 505–10. doi:10.1016/j.ijrobp.2005.02.024. PMID 16168842.
- ↑ Herman JM, Pierce LJ, Sandler HM, Griffith KA, Jabbari S, Hiniker SM; et al. (2008). "Radiotherapy using a water bath in the treatment of Bowen's disease of the digit". Radiother Oncol. 88 (3): 398–402. doi:10.1016/j.radonc.2008.05.025. PMID 18571754.
- ↑ Goodman CR, DeNittis A (2017). "Photon irradiation using a water bath technique for treatment of confluent carcinoma in situ of the hand, digits, and nail bed: a case report". J Med Case Rep. 11 (1): 86. doi:10.1186/s13256-017-1233-3. PMC 5372342. PMID 28356127.
- ↑ Hunt WT, Cameron A, Craig P, de Berker DA (2013). "Multiple-digit periungual Bowen's disease: a novel treatment approach with radiotherapy". Clin Exp Dermatol. 38 (8): 857–61. doi:10.1111/ced.12149. PMID 23937119.
- ↑ Dupree MT, Kiteley RA, Weismantle K, Panos R, Johnstone PA (2001). "Radiation therapy for Bowen's disease: lessons for lesions of the lower extremity". J Am Acad Dermatol. 45 (3): 401–4. doi:10.1067/mjd.2001.116581. PMID 11511838.